CRPC w/ Bone Metastases
Radium-223 Therapy for Patients with Metastatic Castrate-Resistant Prostate Cancer: An Update on Literature with Case Presentation
November 2, 2016
Radium-223: Insight and Perspectives in Bone-metastatic Castration-resistant Prostate Cancer
November 1, 2016
Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone
November 1, 2016
Current therapeutic options targeting bone metastasis in metastatic castration resistant prostate cancer
October 3, 2016
2016 ESMO Congress - Bayer to Showcase Latest Oncology Research
September 28, 2016
Radium-223 Use in Clinical Practice and Variables Associated With Completion of Therapy
September 28, 2016
68Ga-PSMA-11 PET as a gate-keeper for the treatment of metastatic prostate cancer with radium-223: proof of concept
September 27, 2016
How I do it: Prescribing abiraterone acetate for metastatic castration resistant prostate cancer
August 25, 2016
No man's land: information needs and resources of men with metastatic castrate resistant prostate cancer
August 4, 2016
[Metastatic castration-resistant prostate cancer : Clinical data, new treatment options and therapy monitoring]
July 21, 2016